The urokinase-type plasminogen activator system in cancer and other pathological conditions: introduction and perspective.
about
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisUrokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes.Tumor-associated proteolytic factors uPA and PAI-1: critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms.Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array
P2860
The urokinase-type plasminogen activator system in cancer and other pathological conditions: introduction and perspective.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The urokinase-type plasminogen ...... introduction and perspective.
@ast
The urokinase-type plasminogen ...... introduction and perspective.
@en
type
label
The urokinase-type plasminogen ...... introduction and perspective.
@ast
The urokinase-type plasminogen ...... introduction and perspective.
@en
prefLabel
The urokinase-type plasminogen ...... introduction and perspective.
@ast
The urokinase-type plasminogen ...... introduction and perspective.
@en
P1476
The urokinase-type plasminogen ...... introduction and perspective.
@en
P2093
Steven Rosenberg
P304
4p following Table of Contents
P356
10.2174/138161281030900IV
P577
2003-01-01T00:00:00Z